- Home
- Labeler Index
- Bayer Healthcare Pharmaceuticals Inc.
- 50419-391
- NDC Crossover: 50419-391 Vitrakvi
NDC Crossover 50419-391 Vitrakvi
View and Compare Similar Products, Alternatives & Options
NDC Crossover of Similar Products Matching Larotrectinib
Explore similar products and medications to NDC 50419-391 Vitrakvi a human prescription drug with other products crossover matching the same product name (Vitrakvi) or generic name (Larotrectinib), and the same administration route (oral) or dosage form (capsule). This comprehensive list of related drugs for easy comparison is ideal for healthcare professionals & patients seeking alternatives.
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Product Type |
|---|---|---|---|---|---|---|
| 50419-390 | Vitrakvi | Larotrectinib | Capsule | Oral | Bayer Healthcare Pharmaceuticals Inc. | Human Prescription Drug |
| 71777-390 | Vitrakvi | Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | Human Prescription Drug |
| 71777-391 | Vitrakvi | Larotrectinib | Capsule | Oral | Loxo Oncology, Inc. | Human Prescription Drug |
| 71777-392 | Vitrakvi | Larotrectinib | Solution | Oral | Loxo Oncology, Inc. | Human Prescription Drug |